Detection of the EML4-ALK fusion gene in non-small cell lung cancer: our FISH service to date

被引：0
|
作者：
Durajczyk, Clare [1 ]
Massie, D. [1 ]
Stevenson, D. [1 ]
Kerr, K. [2 ]
Smith, L. [1 ]
机构：
[1] Aberdeen Royal Infirm, NE Scotland Genet Lab, Aberdeen, Scotland
[2] Aberdeen Royal Infirm, Dept Pathol, Aberdeen, Scotland
来源：
JOURNAL OF MEDICAL GENETICS | 2012年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [31] The detection of EML4-ALK fusion oncogen in non-small cell lung cancer by Immunohistochemistry (IHC) assay with two different antibodies
    Garcia Martin, R. M.
    Ponce Aix, S.
    Riveiro, E.
    Enguita Valls, A. B.
    VIRCHOWS ARCHIV, 2014, 465 : S375 - S375
  • [32] ANALYSIS OF EML4-ALK POSITIVE NON-SMALL CELL LUNG CANCER WITH ADVANCED STAGE
    Park, J.
    Kondo, C.
    Shimizu, J.
    Horio, Y.
    Yoshida, K.
    Yatabe, Y.
    Mitsudomi, T.
    Hida, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 433 - 434
  • [33] Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations
    Zhou Shaozhang
    Lin Xiaomei
    Zeng Aiping
    He Jianbo
    Song Xiangqun
    Yu Qitao
    GENES CHROMOSOMES & CANCER, 2012, 51 (10): : 925 - 932
  • [34] Identification of a potent kinase inhibitor targeting EML4-ALK fusion protein in non-small cell lung cancer
    Luo, Lian-Xiang
    Li, Ying
    Niu, Yu-Zhen
    Wang, Yu-Wei
    Wang, Qian-Qian
    Fan, Xing-Xing
    Xu, Jia-Hui
    Liu, Liang
    Leung, Elaine Lai-Han
    Yao, Xiao-Jun
    MEDCHEMCOMM, 2017, 8 (10) : 1914 - 1918
  • [35] Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancer
    Tao, Hong
    Shi, Liang
    Zhou, Aoxue
    Li, Hongxia
    Gai, Fei
    Huang, Zhan
    Che, Nanying
    Liu, Zhe
    LUNG CANCER, 2020, 149 : 154 - 161
  • [36] ALK Inhibitors Do Not Increase Sensitivity to Radiation in EML4-ALK Non-small Cell Lung Cancer
    Fleschutz, Kathrin
    Walter, Lisa
    Leistner, Rumo
    Heinzerling, Lucie
    ANTICANCER RESEARCH, 2020, 40 (09) : 4937 - 4946
  • [37] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
    Bilgin, Burak
    Sendur, Mehmet Ali Nahit
    Yucel, Sebnem
    Hizal, Mutlu
    Guner, Gurkan
    Akyurek, Nalan
    Erol, Cihan
    Akinci, Muhammed Bulent
    Dede, Didem Sener
    Yalcin, Bulent
    Kilickap, Sadettin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2637 - 2643
  • [38] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
    Burak Bilgin
    Mehmet Ali Nahit Şendur
    Şebnem Yücel
    Mutlu Hizal
    Gürkan Güner
    Nalan Akyürek
    Cihan Erol
    Muhammed Bülent Akıncı
    Didem Şener Dede
    Bülent Yalçın
    Sadettin Kılıçkap
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2637 - 2643
  • [39] Detection of EML4-ALK fusion gene expression in circulating tumor cells (CTCs) captured from non-small cell lung cancer (NSCLC) patients
    Park, Joo Kyung
    Ryu, Ji Kon
    Lee, Se-Hoon
    Kim, Eun-Hye
    Kim, Byung-Chul
    CANCER RESEARCH, 2014, 74 (19)
  • [40] EML4-ALK Fusion in Lung
    Mano, Hiroyuki
    Takeuchi, Kengo
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (03): : 1552 - 1553
12345